FI941292A - Hemolyysin estäminen - Google Patents

Hemolyysin estäminen Download PDF

Info

Publication number
FI941292A
FI941292A FI941292A FI941292A FI941292A FI 941292 A FI941292 A FI 941292A FI 941292 A FI941292 A FI 941292A FI 941292 A FI941292 A FI 941292A FI 941292 A FI941292 A FI 941292A
Authority
FI
Finland
Prior art keywords
haemolysis
prevention
Prior art date
Application number
FI941292A
Other languages
English (en)
Swedish (sv)
Other versions
FI941292A0 (fi
Inventor
Paul B Weisz
Edward J Macarak
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of FI941292A0 publication Critical patent/FI941292A0/fi
Publication of FI941292A publication Critical patent/FI941292A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI941292A 1991-09-19 1994-03-18 Hemolyysin estäminen FI941292A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/762,606 US5446030A (en) 1991-09-19 1991-09-19 Prevention of hemolysis
PCT/US1992/008037 WO1993005791A1 (en) 1991-09-19 1992-09-18 Prevention of hemolysis

Publications (2)

Publication Number Publication Date
FI941292A0 FI941292A0 (fi) 1994-03-18
FI941292A true FI941292A (fi) 1994-05-18

Family

ID=25065556

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941292A FI941292A (fi) 1991-09-19 1994-03-18 Hemolyysin estäminen

Country Status (9)

Country Link
US (2) US5446030A (fi)
EP (1) EP0649308A1 (fi)
JP (1) JPH06511006A (fi)
AU (1) AU2683292A (fi)
BR (1) BR9206515A (fi)
CA (1) CA2119005A1 (fi)
FI (1) FI941292A (fi)
NO (1) NO940991L (fi)
WO (1) WO1993005791A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
WO2003086283A2 (en) * 2002-04-09 2003-10-23 Greenville Hospital System Metastasis modulating activity of highly sulfated oligosaccharides
WO2004026255A2 (en) * 2002-09-20 2004-04-01 La Jolla Biosciences Compositions and methods for preventing infection
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
MX357677B (es) 2009-05-29 2018-07-19 Cydex Pharmaceuticals Inc Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas.
EP2490751B1 (en) 2009-10-23 2016-11-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
WO2012175434A1 (en) 2011-06-20 2012-12-27 Glaxo Group Limited Pharmaceutical formulations comprising vestipitant

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH445129A (fr) * 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
JPS5036422A (fi) * 1973-08-07 1975-04-05
JPS5311000B2 (fi) * 1974-04-18 1978-04-18
US4020160A (en) * 1975-08-15 1977-04-26 American Cyanamid Company Cyclodextrin sulfate salts as complement inhibitors
US4066829A (en) * 1976-07-12 1978-01-03 American Cyanamid Company Malto-dextrin poly(H-)sulfates
JPS5336220A (en) * 1976-09-16 1978-04-04 Mitsubishi Electric Corp Ultrasonic atomizer
US4258180A (en) * 1979-11-05 1981-03-24 American Cyanamid Company C6-Modified cyclodextrin sulfate salts as complement inhibitors
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
DE2947742C2 (de) * 1979-11-27 1986-04-03 Koch, Jürgen, Dr., 2000 Hamburg Arzneimittel, enthaltend β-Cyclodextrin
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
HU190584B (en) * 1983-03-11 1986-09-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara,Rt,Hu Process for the production of heptakis/2,6-di-o-methyl-beta-cyclodextrin
EP0146841A3 (de) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4703042A (en) * 1984-05-21 1987-10-27 Bodor Nicholas S Orally active heparin salts containing multivalent cationic units
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
JPS62123196A (ja) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd プレドニゾロン包接化合物
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH085923B2 (ja) * 1986-11-12 1996-01-24 和光純薬工業株式会社 新規なシクロデキストリン誘導体及びその製法
EP0340305B1 (en) * 1987-01-13 1993-04-21 Kao Corporation Hemolysis inhibitor and plasticizer
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
HU201783B (en) * 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
IE64346B1 (en) * 1988-01-19 1995-07-26 Moses Judah Folkman Growth inhibiting agent and the use thereof
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
EP0325199B1 (en) * 1988-01-19 1993-10-27 Takeda Chemical Industries, Ltd. Fumagillin as angiostatic agent
US5183809A (en) * 1990-02-15 1993-02-02 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Cyclodextrin polymers and cyclodextrins immobilized on a solid surface
JP2751344B2 (ja) * 1988-03-18 1998-05-18 武田薬品工業株式会社 β―シクロデキストリン硫酸エステル塩の精製方法
US4902788A (en) * 1988-09-29 1990-02-20 Uop Crosslinked cyclodextrins supported on porous refractory inorganic oxides
DE69104877T2 (de) * 1990-03-15 1995-03-16 Tanabe Seiyaku Co Polysulfat eines Cyclodextrinderivates und Verfahren zu dessen Herstellung.
US5100878A (en) * 1990-05-07 1992-03-31 American Maize-Products Company Blocking the effect of teratogens on a fetus

Also Published As

Publication number Publication date
US5776914A (en) 1998-07-07
FI941292A0 (fi) 1994-03-18
NO940991D0 (no) 1994-03-18
WO1993005791A1 (en) 1993-04-01
BR9206515A (pt) 1995-10-31
JPH06511006A (ja) 1994-12-08
EP0649308A4 (en) 1994-06-22
CA2119005A1 (en) 1993-04-01
US5446030A (en) 1995-08-29
EP0649308A1 (en) 1995-04-26
AU2683292A (en) 1993-04-27
NO940991L (no) 1994-05-18

Similar Documents

Publication Publication Date Title
DE69124516D1 (de) Katheter
FI920718A (fi) Vaetskefoerdelare med indraget foerdelningsmunstycke
FI915242A (fi) Rf-skaermning av kretskort
FI920440A (fi) Squid-maetningsanordning foersedd med skyddsorgan
FI923497A (fi) Roterande anslutning med laonglivad taetning
FI922774A (fi) Effektfaktorkorrigerande enstegsomvandlare med en isolerad utgaong
FI941292A (fi) Hemolyysin estäminen
FI88322B (fi) Med ledbommar foersedd arbetsmaskin
IS1605B (is) Botnv”rpuutbunathur
FI922274A (fi) Med slaeckningsgas fungerande flerstaellningsvridstaellare
DE69221031D1 (de) Entwicklungsgerät
FI921921A (fi) Hydrocyklonseparator med turbulensskydd
FI912080A (fi) Lagringslaoda foersedd med en gavelvaeggen slutande genomsynlig klaffskiva
FI920393A (fi) Radio- och landfoerbindelsetelefoner med hands-free-funktion
ITMI912654A1 (it) Combinazione di estrusore-calandra
FI920834A (fi) Med fukos maerkta cytostater
DE69212023D1 (de) Entwicklungsgerät
FI920953A (fi) Belaeggningskopp med tvao ingaongar foer fiberbandkabel
DE69218215D1 (de) Entfernung von schwefelwasserstoff
FI922041A (fi) Planprodukt med perforerade kantfoerstaerkningsband
DE69117493T2 (de) Entwicklungsgerät
KR920019109U (ko) 증류기
IT225839Y1 (it) Struttura di pattino
DE9218159U1 (de) Hosenbuegler
ES1018982Y (es) "braga-compresa"

Legal Events

Date Code Title Description
FD Application lapsed